The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial
Mohamed Y. Abdelgaied, Mohamed Hamed Rashad, Hend Mohamed El-Tayebi, Mohamed H. Solayman
Topics & Concepts
Multiple sclerosisMedicineRelapsing remittingNeurologyMetforminInterferon beta-1aNeuroradiologyInternal medicineInterferon beta-1bRandomized controlled trialInterferon betaOncologyAdjuvantImmunologyPsychiatryInsulinMultiple Sclerosis Research StudiesPsoriasis: Treatment and PathogenesisWhipple's Disease and Interleukins